Aetna Inc (AET) Given Consensus Rating of “Buy” by Analysts

Shares of Aetna Inc (NYSE:AET) have been given an average rating of “Buy” by the twenty-six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Twelve analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $171.88.

Several research firms have issued reports on AET. Wells Fargo & Co restated an “outperform” rating and set a $208.00 target price (up previously from $200.00) on shares of Aetna in a research note on Monday, December 4th. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price on the stock in a research note on Wednesday, January 3rd. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a research note on Wednesday, December 20th. Finally, Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 price objective on the stock. in a research note on Wednesday, December 6th.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. KAMES CAPITAL plc raised its stake in Aetna by 22.6% during the 4th quarter. KAMES CAPITAL plc now owns 265,793 shares of the company’s stock worth $48,008,000 after acquiring an additional 49,077 shares during the period. Milestone Resources Group Ltd bought a new stake in Aetna during the 4th quarter worth approximately $35,385,000. Prudential Financial Inc. raised its stake in Aetna by 3.6% during the 3rd quarter. Prudential Financial Inc. now owns 1,089,269 shares of the company’s stock worth $173,205,000 after acquiring an additional 38,223 shares during the period. Parametric Portfolio Associates LLC raised its stake in Aetna by 3.3% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,124,251 shares of the company’s stock worth $178,767,000 after acquiring an additional 36,129 shares during the period. Finally, AXA raised its stake in Aetna by 16.6% during the 3rd quarter. AXA now owns 274,863 shares of the company’s stock worth $43,706,000 after acquiring an additional 39,125 shares during the period. Institutional investors own 87.69% of the company’s stock.

Aetna (AET) opened at $184.20 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. The stock has a market cap of $60,070.00, a PE ratio of 34.05, a price-to-earnings-growth ratio of 1.59 and a beta of 0.61. Aetna has a one year low of $116.04 and a one year high of $192.37.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.07 EPS. equities research analysts forecast that Aetna will post 9.78 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.09%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 36.97%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://weekherald.com/2018/01/16/aetna-inc-aet-given-consensus-rating-of-buy-by-analysts.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply